Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 185,000 shares at $0.09 ($20K) on 2022-10-11, disclosed to the SEC on 2022-10-12.
Seasonal purchase ($20k) by Chairman and CEO, 10% Owner — this insider has traded EMMA in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.20 | 6,000 | $1K | 5.9% |
| 2 | $0.20 | 5,000 | $1K | 4.9% |
| 3 | $0.20 | 10,000 | $2K | 9.8% |
| 4 | $0.16 | 5,000 | $800 | 3.9% |
| 5 | $0.15 | 10,000 | $2K | 7.4% |
| 6 | $0.15 | 5,000 |
| $750 |
| 3.7% |
| 7 | $0.13 | 4,000 | $520 | 2.6% |
| 8 | $0.09 | 10,000 | $900 | 4.4% |
| 9 | $0.09 | 130,000 | $12K | 57.4% |
| Total | $0.11 avg | 185,000 | $20K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |